Table 1. | Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

Open accessCopyright infoDownload PDFDownload figures

Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice

Table 1.

Affiliation details

University of Washington, United States; Fred Hutchinson Cancer Research Center, United States; University of Missouri, United States
Table 1.

Sex-segregated comparison of median and mean post-treatment life expectancy for mice receiving rapamycin by injection (8 mg/kg/day) or feeding (128 ppm). M: males, F: females.

DOI: http://dx.doi.org/10.7554/eLife.16351.008

Median life expectancy (days)Percent life expectancy increaseMean life expectancy (days)Percent life expectancy increase
Vehicle M231235
Rapamycin (8mg/kg/day) M3726135853
Vehicle F161177
Rapamycin (8mg/kg/day) F1610171-3
Eudragit M193199
Rapamycin (126 ppm) M27944.624221
Eudragit F184175
Rapamycin (126 ppm) F2563924037